Veradigm (MDRX) Stock Chart & Stock Price History $4.85 0.00 (0.00%) As of 03:47 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesSEC FilingsSustainabilityTrendsBuy This Stock Veradigm Stock Price Performance The Veradigm (MDRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 49.48%, with a year-to-date return of -50.26%. In the past month, the stock has increased 5.43%, reflecting recent market activity. As of the latest close, Veradigm traded at $4.85 with a market cap of $525.09 million and volume of 46,624 shares. Five years ago, the stock traded at $9.16, representing a 47.05% decrease over that period. At the time, it had a market cap of $1.52 billion and a volume of 941,200 shares. Receive MDRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Veradigm and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.43%1 Month Performance+5.43%3 Month Performance+10.23%Year-To-Date Performance-50.26%1 Year Performance-49.48%5 Year Performance-47.05% MDRX Stock Chart for Friday, August, 22, 2025 MDRX Chart by TradingView Veradigm Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$4.85$4.85$4.90$4.80185,734 shs$525.09 million08/21/2025$4.90$4.85-1.02%$5.00$3.0046,624 shs$525.09 million08/20/2025$4.80$4.90+2.08%$4.90$4.60109,905 shs$530.50 million08/19/2025$4.65$4.80+3.23%$4.85$4.60186,613 shs$519.67 million08/18/2025$4.60$4.65+1.09%$4.65$3.004,394 shs$503.43 million08/15/2025$4.60$4.60$4.60$4.602,305 shs$498.02 million08/14/2025$4.70$4.60-2.13%$4.68$4.6014,247 shs$498.02 million08/13/2025$4.65$4.70+1.08%$4.85$4.60283,933 shs$508.85 million08/12/2025$4.65$4.65$5.00$4.655,030 shs$503.43 million08/11/2025$4.75$4.65-2.11%$4.70$4.6535,105 shs$503.43 million Get the Latest News and Ratings for MDRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Veradigm and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$4.68$4.75+1.50%$4.80$4.6514,420 shs$514.26 million08/07/2025$4.75$4.68-1.47%$4.75$4.6812,858 shs$506.68 million08/06/2025$4.75$4.75$4.83$4.6535,003 shs$514.26 million08/05/2025$4.85$4.75-2.06%$4.80$4.6816,110 shs$514.26 million08/04/2025$4.85$4.85$4.90$4.68623 shs$525.09 million08/01/2025$4.70$4.85+3.19%$4.85$4.6510,266 shs$525.09 million07/31/2025$4.68$4.70+0.43%$4.90$4.6564,026 shs$508.85 million07/30/2025$4.65$4.68+0.65%$4.75$4.5016,122 shs$506.68 million07/29/2025$4.68$4.65-0.64%$4.70$4.6540,960 shs$503.43 million07/28/2025$4.65$4.68+0.65%$5.00$4.651,801 shs$506.68 million07/25/2025$4.83$4.65-3.73%$4.65$4.602,339 shs$503.43 million07/24/2025$4.65$4.83+3.87%$4.83$4.6541,355 shs$522.92 million07/23/2025$4.60$4.65+1.09%$5.00$4.6528,174 shs$503.43 million07/22/2025$4.60$4.60$4.85$4.6012,655 shs$498.02 million07/21/2025$4.90$4.60-6.12%$4.90$4.6065,864 shs$498.02 million Related Companies Omnicell Stock Chart HealthStream Stock Chart Cortexyme Stock Chart Canna-Global Acquisition Stock Chart OMNIQ Stock Chart Kubient Stock Chart Belive Stock Chart CID Holdco Stock Chart Science Applications International Stock Chart HNI Stock Chart Receive MDRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Veradigm and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MDRX) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veradigm Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Veradigm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access